Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products, net | $328,689 | $513,123 | $659,204 | $1,124,646 |
| Collaboration and other | 72,562 | 97,968 | 472,850 | 231,301 |
| Total revenues | 401,251 | 611,091 | 1,132,054 | 1,355,947 |
| Cost and expenses: | ||||
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Research and development | 91,258 | 204,392 | 245,218 | 977,840 |
| Selling, general and administrative | 107,600 | 137,897 | 216,551 | 271,526 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — revenue of $401.25M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — revenue decreased by 34.3% year-over-year, from $611.09M to $401.25M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — revenue?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — revenue has grown at a 33.1% compound annual growth rate (CAGR), from $933.01M to $2.2B.
- What does business segments — revenue mean?
- Represents the total gross income generated by the business segment from the sale of goods or services. This metric serves as a primary indicator of the segment's market demand and top-line growth performance.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude